LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Withaferin A | 10.0 | uM | LJP6 | 2 | G13 | 72 | hr | 1657 | 1035 | 5505 | 0.1880 | -0.1618 |
BT-20 | Withaferin A | 10.0 | uM | LJP6 | 3 | G13 | 72 | hr | 1657 | 1044 | 5505 | 0.1896 | -0.1595 |
BT-20 | WYE-125132 | 10.0 | uM | LJP6 | 1 | L07 | 72 | hr | 1657 | 1988 | 5505 | 0.3611 | 0.0858 |
BT-20 | WYE-125132 | 10.0 | uM | LJP6 | 2 | L07 | 72 | hr | 1657 | 2068 | 5505 | 0.3756 | 0.1066 |
BT-20 | WYE-125132 | 10.0 | uM | LJP6 | 3 | L07 | 72 | hr | 1657 | 2002 | 5505 | 0.3636 | 0.0895 |
BT-20 | WZ3105 | 10.0 | uM | LJP5 | 1 | D19 | 72 | hr | 1657 | 1044 | 5505 | 0.1896 | -0.1595 |
BT-20 | WZ3105 | 10.0 | uM | LJP5 | 2 | D19 | 72 | hr | 1657 | 1094 | 5505 | 0.1987 | -0.1465 |
BT-20 | WZ3105 | 10.0 | uM | LJP5 | 3 | D19 | 72 | hr | 1657 | 1242 | 5505 | 0.2256 | -0.1080 |
BT-20 | XMD11-50 | 10.0 | uM | LJP6 | 1 | P07 | 72 | hr | 1657 | 2406 | 5505 | 0.4370 | 0.1945 |
BT-20 | XMD11-50 | 10.0 | uM | LJP6 | 2 | P07 | 72 | hr | 1657 | 2449 | 5505 | 0.4448 | 0.2056 |
BT-20 | XMD11-50 | 10.0 | uM | LJP6 | 3 | P07 | 72 | hr | 1657 | 2245 | 5505 | 0.4078 | 0.1526 |
BT-20 | Y39983 | 10.0 | uM | LJP6 | 1 | P01 | 72 | hr | 1657 | 2169 | 5505 | 0.3940 | 0.1329 |
BT-20 | Y39983 | 10.0 | uM | LJP6 | 2 | P01 | 72 | hr | 1657 | 2109 | 5505 | 0.3831 | 0.1173 |
BT-20 | Y39983 | 10.0 | uM | LJP6 | 3 | P01 | 72 | hr | 1657 | 2459 | 5505 | 0.4466 | 0.2082 |
BT-20 | YM 201636 | 10.0 | uM | LJP5 | 1 | N07 | 72 | hr | 1657 | 2187 | 5505 | 0.3972 | 0.1375 |
BT-20 | YM 201636 | 10.0 | uM | LJP5 | 2 | N07 | 72 | hr | 1657 | 2236 | 5505 | 0.4061 | 0.1503 |
BT-20 | YM 201636 | 10.0 | uM | LJP5 | 3 | N07 | 72 | hr | 1657 | 2005 | 5505 | 0.3642 | 0.0902 |
BT-20 | ZSTK474 | 10.0 | uM | LJP6 | 1 | M13 | 72 | hr | 1657 | 1302 | 5505 | 0.2365 | -0.0925 |
BT-20 | ZSTK474 | 10.0 | uM | LJP6 | 2 | M13 | 72 | hr | 1657 | 1617 | 5505 | 0.2937 | -0.0106 |
BT-20 | ZSTK474 | 10.0 | uM | LJP6 | 3 | M13 | 72 | hr | 1657 | 1711 | 5505 | 0.3108 | 0.0138 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 929 | 3002 | 3228 | 0.9300 | 0.9017 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 929 | 3085 | 3228 | 0.9557 | 0.9378 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 929 | 3122 | 3228 | 0.9671 | 0.9539 |
Hs 578T | Sigma A6730 | 0.04 | uM | LJP5 | 1 | B24 | 72 | hr | 929 | 3126 | 3228 | 0.9684 | 0.9556 |
Hs 578T | Sigma A6730 | 0.04 | uM | LJP5 | 2 | B24 | 72 | hr | 929 | 3283 | 3228 | 1.0170 | 1.0239 |